RUSSIAN DRUG PRICES SET TO QUADRUPLE
Prices of medicines and drugs in Russia will go up by an average of 400% when prices are freed, according to Andrei Vorobev, Russian Federation Minister of Health, and Aleksandr Apazov, director of the association of medicines producers.
Unless a reform of pharmaceutical pricing is carried out quickly, pharmacies will be left with no medicines to sell, they warn. In this situation, the Health Ministry believes that its main task would be to ensure the survival of people suffering from serious illnesses.
So far, Boris Yeltsin's Russian government has allocated 1.35 billion foreign currency roubles to deal with the drugs shortage, and the Ministry has said that it plans to stop purchasing finished medicines and will instead buy equipment and raw materials, so that drugs can be produced at Russian enterprises.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze